Compliance & EnforcementFalse Claims Act
ArchiveFalse Claims Act
3,592 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Second Circuit Emphasizes Heightened Pleading Standard for Qui Tam FCA Suits
Private Equity Firm Settles FCA Case
The FY2018 Suspension and Debarment Report
FY2019 Suspension/Debarment Activity
FCA Does Not Preclude Prevailing Defendants from Recovering Certain Litigation Costs; United States District Court for the District of New Jersey No. 1:08-cv-2126-NLH-AMD, Victoria Druding, et al. v Care Alternatives
Increased False Claims Act Scrutiny for Private Equity Firms Investing in Healthcare Providers
California Health System and Surgical Group Agree to Settle Claims Arising from Improper Compensation Arrangements
Criminal Fraud Convictions Determine Defendants’ Fates in Civil FCA Case; United States District Court for the Northern District of Texas, Dallas Division No. 3:13-CV-00023-M, U.S. ex rel. Gordan Grant Bachman v. Healthcare Liaison Professionals Inc. dba US Physician Home Visits, et al.
Products Offered on GSA Schedules Not Open Market; United States District Court for the Northern District of California No. C 19-00173 WHA, U.S. ex rel. Matthew MacDowell v. Synnex Corporation
Updated Civil Monetary Penalties
DOJ Continues False Claims Act Enforcement in Transportation Industry
United States Files False Claims Act Complaint against South Dakota Neurosurgeon and Physician-Owned Distributorships
Knowing Retention of Improper Overpayment Enough to Support Allegation of Reverse False Claim; United States District Court for the Middle District of Florida, Tampa Division No. 8:15-cv-1044-T-33AEP, U.S. ex rel. Corina Herbold v. Doctor’s Choice Home Care Inc., et al.
Third Circuit Holds False Claims Act Relator Lacks Standing and Right to Intervene in Related Criminal Case
DOJ Successfully Obtains Dismissal of FCA Case Potentially Undermining FDA, CMS Decision-Making; U.S. District Court for the Northern District of California No. 11-cv-00941-EMC, U.S. ex rel. Jeff and Sherilyn Campie v. Gilead Sciences Inc., et al.
At Long Last, Court Grants DOJ’s Granston Motion in Campie
The False Claims Act: Yesterday, Today, and Tomorrow: What A Long Strange Trip It’s Been Part III: Tomorrow
Relator Failed to Identify Specific False Claims for Payment, but Plausibly Alleged Defendants Knew They Were Breaking Program Funding Rules; United States District Court for the Central District of California No. 2:18-cv-05964-CAS(RAOx), U.S. ex rel. Nathan S. Lewis v. California Institute of Technology, et al.
Tenth Circuit Affirms an Award of Attorneys’ Fees for a Successful FCA Defendant
Keep reading
